▶ 調査レポート

心臓マーカーの世界市場レポート2020

• 英文タイトル:Global Cardiac Marker Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。心臓マーカーの世界市場レポート2020 / Global Cardiac Marker Sales Market Report 2020 / 20QY06-06746資料のイメージです。• レポートコード:20QY06-06746
• 出版社/出版日:QYResearch / 2020年6月3日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、143ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、心臓マーカーのグローバル市場について種類別(クレアチンキナーゼ(CK)MB、トロポニン(cTnI及びcTnT)、BNP及びNT-proBNP、ミオグロブリン、その他(hs-CRP、D-Dimer))、用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・心臓マーカー市場の概要
・世界の主要地域別心臓マーカー市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の心臓マーカー市場規模2015-2026:種類別(クレアチンキナーゼ(CK)MB、トロポニン(cTnI及びcTnT)、BNP及びNT-proBNP、ミオグロブリン、その他(hs-CRP、D-Dimer))
・世界の心臓マーカー市場規模2015-2026:用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)
・心臓マーカーの北米市場規模2015-2020
・心臓マーカーのヨーロッパ市場規模2015-2020
・心臓マーカーの中国市場規模2015-2020
・心臓マーカーの日本市場規模2015-2020
・心臓マーカーの東南アジア市場規模2015-2020
・心臓マーカーのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(HyTest、、Abbott、、Roche Diagnostics、、BG Medicine、、Biomerieux、、Critical Diagnostics、、DiaDexus、、Response Biomedical、、Siemens Healthcare、、Singulex、、Thermo Scientific、、Trinity Biotech、、Sunfory、、Lee BioSolutions、)
・心臓マーカーの製造コスト分析
・販売チャネル、流通業者、顧客
・心臓マーカーの市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Cardiac Marker Market

The global Cardiac Marker market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.

Global Cardiac Marker Scope and Market Size

The global Cardiac Marker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Marker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Cardiac Marker market is segmented into

Creatine kinase (CK) MB

Troponin (cTnI and cTnT)

BNP & NT-proBNP

Myogloblin

Others (hs-CRP, D-Dimer, etc.)

Segment by Application, the Cardiac Marker market is segmented into

Myocardial Infarction

Congestive Heart Failure

Acute Coronary Syndrome

Atherosclerosis

Others

The Cardiac Marker market is analysed and market size information is provided by regions (countries). Segment by Application, the Cardiac Marker market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Cardiac Marker Market Share Analysis

Cardiac Marker market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cardiac Marker business, the date to enter into the Cardiac Marker market, Cardiac Marker product introduction, recent developments, etc.

The major vendors covered:

HyTest

Abbott

Roche Diagnostics

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

Response Biomedical

Siemens Healthcare

Singulex

Thermo Scientific

Trinity Biotech

Sunfory

Lee BioSolutions

レポート目次

Table of Contents

1 Cardiac Marker Market Overview

1.1 Cardiac Marker Product Scope

1.2 Cardiac Marker Segment by Type

1.2.1 Global Cardiac Marker Sales by Type (2020-2026)

1.2.2 Creatine kinase (CK) MB

1.2.3 Troponin (cTnI and cTnT)

1.2.4 BNP & NT-proBNP

1.2.5 Myogloblin

1.2.6 Others (hs-CRP, D-Dimer, etc.)

1.3 Cardiac Marker Segment by Application

1.3.1 Global Cardiac Marker Sales Comparison by Application (2020-2026)

1.3.2 Myocardial Infarction

1.3.3 Congestive Heart Failure

1.3.4 Acute Coronary Syndrome

1.3.5 Atherosclerosis

1.3.6 Others

1.4 Cardiac Marker Market Estimates and Forecasts (2015-2026)

1.4.1 Global Cardiac Marker Sales Growth Rate (2015-2026)

1.4.2 Global Cardiac Marker Revenue and Growth Rate (2015-2026)

1.4.3 Global Cardiac Marker Price Trends (2015-2026)

2 Cardiac Marker Estimate and Forecast by Region

2.1 Global Cardiac Marker Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Cardiac Marker Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Cardiac Marker Sales Market Share by Region (2015-2020)

2.2.2 Global Cardiac Marker Revenue Market Share by Region (2015-2020)

2.3 Global Cardiac Marker Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Cardiac Marker Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Cardiac Marker Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Cardiac Marker Estimates and Projections (2015-2026)

2.4.2 Europe Cardiac Marker Estimates and Projections (2015-2026)

2.4.3 China Cardiac Marker Estimates and Projections (2015-2026)

2.4.4 Japan Cardiac Marker Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Cardiac Marker Estimates and Projections (2015-2026)

2.4.6 India Cardiac Marker Estimates and Projections (2015-2026)

3 Global Cardiac Marker Competition Landscape by Players

3.1 Global Top Cardiac Marker Players by Sales (2015-2020)

3.2 Global Top Cardiac Marker Players by Revenue (2015-2020)

3.3 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Marker as of 2019)

3.4 Global Cardiac Marker Average Price by Company (2015-2020)

3.5 Manufacturers Cardiac Marker Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Cardiac Marker Players (Opinion Leaders)

4 Global Cardiac Marker Market Size by Type

4.1 Global Cardiac Marker Historic Market Review by Type (2015-2020)

4.1.1 Global Cardiac Marker Sales Market Share by Type (2015-2020)

4.1.2 Global Cardiac Marker Revenue Market Share by Type (2015-2020)

4.1.3 Global Cardiac Marker Price by Type (2014-2020)

4.2 Global Cardiac Marker Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Cardiac Marker Sales Forecast by Type (2021-2026)

4.2.2 Global Cardiac Marker Revenue Forecast by Type (2021-2026)

4.2.3 Global Cardiac Marker Price Forecast by Type (2021-2026)

5 Global Cardiac Marker Market Size by Application

5.1 Global Cardiac Marker Historic Market Review by Application (2015-2020)

5.1.1 Global Cardiac Marker Sales Market Share by Application (2015-2020)

5.1.2 Global Cardiac Marker Revenue Market Share by Application (2015-2020)

5.1.3 Global Cardiac Marker Price by Application (2015-2020)

5.2 Global Cardiac Marker Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Cardiac Marker Sales Forecast by Application (2021-2026)

5.2.2 Global Cardiac Marker Revenue Forecast by Application (2021-2026)

5.2.3 Global Cardiac Marker Price Forecast by Application (2021-2026)

3 North America Cardiac Marker Market Facts & Figures

3.2 North America Cardiac Marker Sales Market Share by Company (2015-2020)

3.3 North America Cardiac Marker Sales Market Share by Type (2015-2020)

3.4 North America Cardiac Marker Sales Market Share by Application (2015-2020)

4 Europe Cardiac Marker Market Facts & Figures

4.2 Europe Cardiac Marker Sales Market Share by Company (2015-2020)

4.3 Europe Cardiac Marker Sales Market Share by Type (2015-2020)

4.4 Europe Cardiac Marker Sales Market Share by Application (2015-2020)

5 China Cardiac Marker Market Facts & Figures

5.2 China Cardiac Marker Sales Market Share by Company (2015-2020)

5.3 China Cardiac Marker Sales Market Share by Type (2015-2020)

5.4 China Cardiac Marker Sales Market Share by Application (2015-2020)

6 Japan Cardiac Marker Market Facts & Figures

6.2 Japan Cardiac Marker Sales Market Share by Company (2015-2020)

6.3 Japan Cardiac Marker Sales Market Share by Type (2015-2020)

6.4 Japan Cardiac Marker Sales Market Share by Application (2015-2020)

7 Southeast Asia Cardiac Marker Market Facts & Figures

7.2 Southeast Asia Cardiac Marker Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Cardiac Marker Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Cardiac Marker Sales Market Share by Application (2015-2020)

8 India Cardiac Marker Market Facts & Figures

8.2 India Cardiac Marker Sales Market Share by Company (2015-2020)

8.3 India Cardiac Marker Sales Market Share by Type (2015-2020)

8.4 India Cardiac Marker Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Cardiac Marker Business

12.1 HyTest

12.1.1 HyTest Cardiac Marker Corporation Information

12.1.2 HyTest Cardiac Marker Business Overview and Total Revenue

12.1.3 HyTest Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.1.4 HyTest Cardiac Marker Products Offered

12.1.5 HyTest Recent Development

12.2 Abbott

12.2.1 Abbott Cardiac Marker Corporation Information

12.2.2 Abbott Cardiac Marker Business Overview and Total Revenue

12.2.3 Abbott Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Abbott Cardiac Marker Products Offered

12.2.5 Abbott Recent Development

12.3 Roche Diagnostics

12.3.1 Roche Diagnostics Cardiac Marker Corporation Information

12.3.2 Roche Diagnostics Cardiac Marker Business Overview and Total Revenue

12.3.3 Roche Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Roche Diagnostics Cardiac Marker Products Offered

12.3.5 Roche Diagnostics Recent Development

12.4 BG Medicine

12.4.1 BG Medicine Cardiac Marker Corporation Information

12.4.2 BG Medicine Cardiac Marker Business Overview and Total Revenue

12.4.3 BG Medicine Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.4.4 BG Medicine Cardiac Marker Products Offered

12.4.5 BG Medicine Recent Development

12.5 Biomerieux

12.5.1 Biomerieux Cardiac Marker Corporation Information

12.5.2 Biomerieux Cardiac Marker Business Overview and Total Revenue

12.5.3 Biomerieux Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Biomerieux Cardiac Marker Products Offered

12.5.5 Biomerieux Recent Development

12.6 Critical Diagnostics

12.6.1 Critical Diagnostics Cardiac Marker Corporation Information

12.6.2 Critical Diagnostics Cardiac Marker Business Overview and Total Revenue

12.6.3 Critical Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Critical Diagnostics Cardiac Marker Products Offered

12.6.5 Critical Diagnostics Recent Development

12.7 DiaDexus

12.7.1 DiaDexus Cardiac Marker Corporation Information

12.7.2 DiaDexus Cardiac Marker Business Overview and Total Revenue

12.7.3 DiaDexus Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.7.4 DiaDexus Cardiac Marker Products Offered

12.7.5 DiaDexus Recent Development

12.8 Response Biomedical

12.8.1 Response Biomedical Cardiac Marker Corporation Information

12.8.2 Response Biomedical Cardiac Marker Business Overview and Total Revenue

12.8.3 Response Biomedical Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Response Biomedical Cardiac Marker Products Offered

12.8.5 Response Biomedical Recent Development

12.9 Siemens Healthcare

12.9.1 Siemens Healthcare Cardiac Marker Corporation Information

12.9.2 Siemens Healthcare Cardiac Marker Business Overview and Total Revenue

12.9.3 Siemens Healthcare Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.9.4 Siemens Healthcare Cardiac Marker Products Offered

12.9.5 Siemens Healthcare Recent Development

12.10 Singulex

12.10.1 Singulex Cardiac Marker Corporation Information

12.10.2 Singulex Cardiac Marker Business Overview and Total Revenue

12.10.3 Singulex Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.10.4 Singulex Cardiac Marker Products Offered

12.10.5 Singulex Recent Development

12.11 Thermo Scientific

12.11.1 Thermo Scientific Cardiac Marker Corporation Information

12.11.2 Thermo Scientific Cardiac Marker Business Overview and Total Revenue

12.11.3 Thermo Scientific Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.11.4 Thermo Scientific Cardiac Marker Products Offered

12.11.5 Thermo Scientific Recent Development

12.12 Trinity Biotech

12.12.1 Trinity Biotech Cardiac Marker Corporation Information

12.12.2 Trinity Biotech Cardiac Marker Business Overview and Total Revenue

12.12.3 Trinity Biotech Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.12.4 Trinity Biotech Cardiac Marker Products Offered

12.12.5 Trinity Biotech Recent Development

12.13 Sunfory

12.13.1 Sunfory Cardiac Marker Corporation Information

12.13.2 Sunfory Cardiac Marker Business Overview and Total Revenue

12.13.3 Sunfory Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.13.4 Sunfory Cardiac Marker Products Offered

12.13.5 Sunfory Recent Development

12.14 Lee BioSolutions

12.14.1 Lee BioSolutions Cardiac Marker Corporation Information

12.14.2 Lee BioSolutions Cardiac Marker Business Overview and Total Revenue

12.14.3 Lee BioSolutions Cardiac Marker Sales, Revenue and Gross Margin (2015-2020)

12.14.4 Lee BioSolutions Cardiac Marker Products Offered

12.14.5 Lee BioSolutions Recent Development

13 Cardiac Marker Manufacturing Cost Analysis

13.1 Cardiac Marker Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Cardiac Marker

13.4 Cardiac Marker Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Cardiac Marker Distributors List

14.3 Cardiac Marker Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables



Table 1. Global Cardiac Marker Sales (K Doses) Growth Rate by Type (2020-2026)

Table 2. Global Cardiac Marker Sales (K Doses) Comparison by Application (2020-2026)

Table 3. Global Market Cardiac Marker Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 4. Global Cardiac Marker Sales (K Doses) by Region (2015-2020)

Table 5. Global Cardiac Marker Sales Market Share by Region (2015-2020)

Table 6. Global Cardiac Marker Revenue (US$ Million) Market Share by Region (2015-2020))

Table 7. Global Cardiac Marker Revenue Share by Region (2015-2020)

Table 8. Global Cardiac Marker Sales (K Doses) Forecast by Region (2021-2026)

Table 9. Global Cardiac Marker Sales Market Share Forecast by Region (2021-2026)

Table 10. Global Cardiac Marker Revenue (US$ Million) Forecast by Region (2021-2026)

Table 11. Global Cardiac Marker Revenue Share Forecast by Region (2021-2026)

Table 12. Global Cardiac Marker (K Doses) of Key Companies (2015-2020)

Table 13. Global Cardiac Marker Sales Share by Company (2015-2020)

Table 14. Global Cardiac Marker Revenue (US$ Million) by Company (2015-2020)

Table 15. Global Cardiac Marker Revenue Share by Company (2015-2020)

Table 16. Global Cardiac Marker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Marker as of 2019)

Table 17. Global Cardiac Marker Average Price (USD/Dose) of Key Company (2015-2020)

Table 18. Manufacturers Cardiac Marker Manufacturing Sites and Area Served

Table 19. Manufacturers Cardiac Marker Product Type

Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 21. Main Points Interviewed from Key Cardiac Marker Players

Table 22. Global Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 23. Global Cardiac Marker Sales Share by Type (2015-2020)

Table 24. Global Cardiac Marker Revenue (US$ Million) Market Share by Type (2015-2020)

Table 25. Global Cardiac Marker Price (K Doses) by Type (2015-2020)

Table 26. Global Cardiac Marker Sales Share by Type (2021-2026)

Table 27. Global Cardiac Marker Revenue (US$ Million) Market Share by Type (2021-2026)

Table 28. Global Cardiac Marker Revenue Share by Type (2021-2026)

Table 29. Global Cardiac Marker Price (K Doses) by Type (2021-2026)

Table 30. Global Cardiac Marker Sales (K Doses) by Application (2015-2020)

Table 31. Global Cardiac Marker Sales Share by Application (2015-2020)

Table 32. Global Cardiac Marker Revenue (US$ Million) Market Share by Application (2015-2020)

Table 33. Global Cardiac Marker Price (K Doses) by Application (2015-2020)

Table 34. Global Cardiac Marker Sales (K Doses) by Application (2021-2026)

Table 35. Global Cardiac Marker Sales Share by Application (2021-2026)

Table 36. Global Cardiac Marker Revenue (US$ Million) Market Share by Application (2021-2026)

Table 37. Global Cardiac Marker Revenue Share by Application (2021-2026)

Table 38. Global Cardiac Marker Price (K Doses) by Application (2021-2026)

Table 39. United States Cardiac Marker Sales (K Doses) by Company (2015-2020)

Table 40. United States Cardiac Marker Sales Market Share by Company (2015-2020)

Table 41. United States Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 42. United States Cardiac Marker Sales Market Share by Type (2015-2020)

Table 43. United States Cardiac Marker Sales (K Doses) by Application (2015-2020)

Table 44. United States Cardiac Marker Sales Market Share by Application (2015-2020)

Table 45. Europe Cardiac Marker Sales (K Doses) by Company (2015-2020)

Table 46. Europe Cardiac Marker Sales Market Share by Company (2015-2020)

Table 47. Europe Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 48. Europe Cardiac Marker Sales Market Share by Type (2015-2020)

Table 49. Europe Cardiac Marker Sales (K Doses) by Application (2015-2020)

Table 50. Europe Cardiac Marker Sales Market Share by Type (2015-2020)

Table 51. China Cardiac Marker Sales (K Doses) by Company (2015-2020)

Table 52. China Cardiac Marker Sales Market Share by Company (2015-2020)

Table 53. China Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 54. China Cardiac Marker Sales Market Share by Type (2015-2020)

Table 55. China Cardiac Marker Sales (K Doses) by Application (2015-2020)

Table 56. China Cardiac Marker Sales Market Share by Application (2015-2020)

Table 57. Japan Cardiac Marker Sales (K Doses) by Company (2015-2020)

Table 58. Japan Cardiac Marker Sales Market Share by Company (2015-2020)

Table 59. Japan Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 60. Japan Cardiac Marker Sales Market Share by Type (2015-2020)

Table 61. Japan Cardiac Marker Sales (K Doses) by Application (2015-2020)

Table 62. Japan Cardiac Marker Sales Market Share by Application (2015-2020)

Table 63. Southeast Asia Cardiac Marker Sales (K Doses) by Company (2015-2020)

Table 64. Southeast Asia Cardiac Marker Sales Market Share by Company (2015-2020)

Table 65. Southeast Asia Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 66. Southeast Asia Cardiac Marker Sales Market Share by Type (2015-2020)

Table 67. Southeast Asia Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 68. Southeast Asia Cardiac Marker Sales Market Share by Application (2015-2020)

Table 69. India Cardiac Marker Sales (K Doses) by Company (2015-2020)

Table 70. India Cardiac Marker Sales Market Share by Company (2015-2020)

Table 71. India Cardiac Marker Sales (K Doses) by Type (2015-2020)

Table 72. India Cardiac Marker Sales Market Share by Type (2015-2020)

Table 73. India Cardiac Marker Sales (K Doses) by Application (2015-2020)

Table 74. India Cardiac Marker Sales Market Share by Application (2015-2020)

Table 75. HyTest Corporation Information

Table 76. HyTest Description and Business Overview

Table 77. HyTest Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 78. HyTest Cardiac Marker Product

Table 79. HyTest Recent Development

Table 80. Abbott Corporation Information

Table 81. Abbott Description and Business Overview

Table 82. Abbott Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 83. Abbott Cardiac Marker Product

Table 84. Abbott Recent Development

Table 85. Roche Diagnostics Corporation Information

Table 86. Roche Diagnostics Description and Business Overview

Table 87. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 88. Roche Diagnostics Cardiac Marker Product

Table 89. Roche Diagnostics Recent Development

Table 90. BG Medicine Corporation Information

Table 91. BG Medicine Description and Business Overview

Table 92. BG Medicine Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 93. BG Medicine Cardiac Marker Product

Table 94. BG Medicine Recent Development

Table 95. Biomerieux Corporation Information

Table 96. Biomerieux Description and Business Overview

Table 97. Biomerieux Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 98. Biomerieux Cardiac Marker Product

Table 99. Biomerieux Recent Development

Table 100. Critical Diagnostics Corporation Information

Table 101. Critical Diagnostics Description and Business Overview

Table 102. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 103. Critical Diagnostics Cardiac Marker Product

Table 104. Critical Diagnostics Recent Development

Table 105. DiaDexus Corporation Information

Table 106. DiaDexus Description and Business Overview

Table 107. DiaDexus Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 108. DiaDexus Cardiac Marker Product

Table 109. DiaDexus Recent Development

Table 110. Response Biomedical Corporation Information

Table 111. Response Biomedical Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 112. Response Biomedical Description and Business Overview

Table 113. Response Biomedical Cardiac Marker Product

Table 114. Response Biomedical Recent Development

Table 115. Siemens Healthcare Corporation Information

Table 116. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 117. Siemens Healthcare Description and Business Overview

Table 118. Siemens Healthcare Cardiac Marker Product

Table 119. Siemens Healthcare Recent Development

Table 120. Singulex Corporation Information

Table 121. Singulex Description and Business Overview

Table 122. Singulex Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 123. Singulex Cardiac Marker Product

Table 124. Singulex Recent Development

Table 125. Thermo Scientific Corporation Information

Table 126. Thermo Scientific Description and Business Overview

Table 127. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 128. Thermo Scientific Cardiac Marker Product

Table 129. Thermo Scientific Recent Development

Table 130. Trinity Biotech Corporation Information

Table 131. Trinity Biotech Description and Business Overview

Table 132. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 133. Trinity Biotech Cardiac Marker Product

Table 134. Trinity Biotech Recent Development

Table 135. Sunfory Corporation Information

Table 136. Sunfory Description and Business Overview

Table 137. Sunfory Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 138. Sunfory Cardiac Marker Product

Table 139. Sunfory Recent Development

Table 140. Lee BioSolutions Corporation Information

Table 141. Lee BioSolutions Description and Business Overview

Table 142. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)

Table 143. Lee BioSolutions Cardiac Marker Product

Table 144. Lee BioSolutions Recent Development

Table 145. Production Base and Market Concentration Rate of Raw Material

Table 146. Key Suppliers of Raw Materials

Table 147. Cardiac Marker Distributors List

Table 148. Cardiac Marker Customers List

Table 149. Market Key Trends

Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 151. Key Challenges

Table 152. Research Programs/Design for This Report

Table 153. Key Data Information from Secondary Sources

Table 154. Key Data Information from Primary Sources

List of Figures

Figure 1. Cardiac Marker Product Picture

Figure 2. Global Cardiac Marker Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Cardiac Marker Market Share by Application in 2020 & 2026

Figure 6. Myocardial Infarction Examples

Figure 7. Congestive Heart Failure Examples

Figure 8. Acute Coronary Syndrome Examples

Figure 9. Atherosclerosis Examples

Figure 10. Others Examples

Figure 11. Global Cardiac Marker Sales (K Doses) Growth Rate (2015-2026)

Figure 12. Global Cardiac Marker Revenue (US$ Million) Growth Rate (2015-2026)

Figure 13. Global Cardiac Marker Price Trends Growth Rate (2015-2026) (USD/Dose)

Figure 14. Global Cardiac Marker Revenue Market Share by Region: 2015 VS 2020

Figure 15. Global Cardiac Marker Revenue Market Share by Region: 2021 VS 2026

Figure 16. United States Cardiac Marker Revenue (Million USD) Growth Rate (2015-2026)

Figure 17. United States Cardiac Marker Sales (K Doses) Growth Rate (2015-2026)

Figure 18. Europe Cardiac Marker Revenue (Million USD) Growth Rate (2015-2026)

Figure 19. Europe Cardiac Marker Sales (Million USD) Growth Rate (2015-2026)

Figure 20. China Cardiac Marker Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. China Cardiac Marker Sales (Million USD) and Growth Rate (2015-2026)

Figure 22. Japan Cardiac Marker Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Japan Cardiac Marker Sales (Million USD) Growth Rate (2015-2026)

Figure 24. Southeast Asia Cardiac Marker Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. Southeast Asia Cardiac Marker Sales (Million USD) Growth Rate (2015-2026)

Figure 26. India Cardiac Marker Revenue (Million USD) Growth Rate (2015-2026)

Figure 27. India Cardiac Marker Sales (Million USD) Growth Rate (2015-2026)

Figure 28. Global 5 Largest Cardiac Marker Players Market Share by Revenue in Cardiac Marker 2015 & 2019

Figure 29. Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 30. Global Cardiac Marker Revenue Share by Type (2015-2020)

Figure 31. Global Cardiac Marker Revenue Growth Rate by Type in 2015 & 2019

Figure 32. Global Cardiac Marker Revenue Share by Application (2015-2020)

Figure 33. Global Cardiac Marker Revenue Growth Rate by Application in 2015 & 2019

Figure 34. United States Cardiac Marker Sales Market Share by Type in 2019

Figure 35. United States Cardiac Marker Sales Market Share by Type in 2019

Figure 36. Europe Cardiac Marker Sales Market Share by Company in 2019

Figure 37. Europe Cardiac Marker Sales Market Share by Type in 2019

Figure 38. Europe Cardiac Marker Sales Market Share by Application in 2019

Figure 39. China Cardiac Marker Sales Market Share by Company in 2019

Figure 40. China Cardiac Marker Sales Market Share by Type in 2019

Figure 41. China Cardiac Marker Sales Market Share by Application in 2019

Figure 42. Japan Cardiac Marker Sales Market Share by Company in 2019

Figure 43. Japan Cardiac Marker Sales Market Share by Type in 2019

Figure 44. Japan Cardiac Marker Sales Market Share by Application in 2019

Figure 45. Southeast Asia Cardiac Marker Sales Market Share by Company in 2019

Figure 46. Southeast Asia Cardiac Marker Sales Market Share by Type in 2019

Figure 47. Southeast Asia Cardiac Marker Sales Market Share by Application in 2019

Figure 48. India Cardiac Marker Sales Market Share by Company in 2019

Figure 49. India Cardiac Marker Sales Market Share by Type in 2019

Figure 50. India Cardiac Marker Sales Market Share by Application in 2019

Figure 51. HyTest Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Abbott Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. BG Medicine Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Biomerieux Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Critical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. DiaDexus Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Response Biomedical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. Singulex Total Revenue (US$ Million): 2019 Compared with 2018

Figure 61. Thermo Scientific Total Revenue (US$ Million): 2019 Compared with 2018

Figure 62. Trinity Biotech Total Revenue (US$ Million): 2019 Compared with 2018

Figure 63. Sunfory Total Revenue (US$ Million): 2019 Compared with 2018

Figure 64. Lee BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018

Figure 65. Key Raw Materials Price Trend

Figure 66. Manufacturing Cost Structure of Cardiac Marker

Figure 67. Manufacturing Process Analysis of Cardiac Marker

Figure 68. Cardiac Marker Industrial Chain Analysis

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Figure 71. Porter's Five Forces Analysis

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed